F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Chronic hepatitis B

Page 1 of 4 ( 190 items )
<<
1
2
3
4
>>

1	Pegylated interferon α-2b add-on to nucleos(t)ide analogues reduces hepatocellular carcinoma and decompensation in advanced fibrotic chronic hepatitis B 10/15/2026 5:45:55 AM \| Browse: 17 \| Download: 59
2	From virological selection to immune stratification: Hepatitis B virus-specific T cells for precision pegylated interferon therapy in chronic hepatitis B 9/17/2026 5:48:20 AM \| Browse: 33 \| Download: 69
3	Biological interpretation of baseline hepatitis B surface antigen and cirrhosis in determining interferon treatment duration 9/7/2026 2:26:33 AM \| Browse: 45 \| Download: 88
4	Predictive model to identify patients requiring extended interferon therapy in chronic hepatitis B 9/1/2026 6:22:40 AM \| Browse: 32 \| Download: 74
5	Routine laboratory model for identifying significant fibrosis in chronic hepatitis B 6/26/2026 9:50:21 AM \| Browse: 59 \| Download: 262
6	Comparing validated hepatocellular carcinoma risk scores for chronic hepatitis B against current Australian surveillance guidelines 6/26/2026 9:50:19 AM \| Browse: 43 \| Download: 218
7	Letter to the Editor: Physical functioning as a neglected determinant of antiviral adherence in chronic hepatitis B 6/18/2026 7:52:55 AM \| Browse: 59 \| Download: 250
8	Bone and renal safety of initial antiviral therapy using tenofovir alafenamide fumarate or entecavir for chronic hepatitis B 5/29/2026 7:26:46 AM \| Browse: 57 \| Download: 347
9	Beyond fibrosis: The imperative for dual steatosis and fibrosis assessment in chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease co-pathology 5/26/2026 3:52:09 AM \| Browse: 44 \| Download: 206
10	Diagnostic efficacy and influencing factors of non-invasive liver fibrosis scores in chronic hepatitis B fibrosis: Cross-sectional study 5/26/2026 3:52:08 AM \| Browse: 68 \| Download: 294
11	Why does hepatitis B remain underprioritized? A view through lived experience 4/23/2026 11:05:50 AM \| Browse: 101 \| Download: 335
12	Baseline hepatitis B surface antigen and cirrhosis predict extended interferon therapy in chronic hepatitis B: A retrospective study 3/19/2026 7:07:29 AM \| Browse: 101 \| Download: 411
13	Predictive tool for evident histological liver injury in chronic hepatitis B patients: Development and validation 2/12/2026 11:20:21 AM \| Browse: 141 \| Download: 584
14	Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B 2/12/2026 11:20:19 AM \| Browse: 142 \| Download: 586
15	Adherence to antiviral treatment among people living with chronic hepatitis B: A global survey 12/25/2025 9:13:55 AM \| Browse: 117 \| Download: 518
16	Retreatment hepatitis B surface antigen clearance prediction model identifies pegylated interferon alpha candidates in chronic hepatitis B 11/28/2025 3:10:38 AM \| Browse: 304 \| Download: 634
17	Meta-analysis of factors associated with the incidence of comorbid depression and anxiety in patients with chronic hepatitis B 11/4/2025 2:41:47 AM \| Browse: 317 \| Download: 770
18	Gray zone and the need for expansion in chronic hepatitis B: From theory to clinical practice 10/27/2025 10:57:50 AM \| Browse: 438 \| Download: 614
19	Association of serum hepatitis B surface antigen with hepatitis B virus DNA and hepatic function in patients with chronic hepatitis B 10/24/2025 7:36:34 AM \| Browse: 362 \| Download: 555
20	Association between hepatitis B virus markers and liver fibrosis staging in patients with chronic hepatitis B 10/24/2025 7:36:26 AM \| Browse: 219 \| Download: 467
21	Psychological distress and treatment adherence-challenges of patients with chronic hepatitis B: Risk factors and integrated nursing strategies 9/26/2025 8:18:47 AM \| Browse: 569 \| Download: 579
22	Functional cure in an occult hepatitis B virus infection patient on sequential therapy: A case report 9/25/2025 11:24:05 AM \| Browse: 189 \| Download: 589
23	Anti-hepatitis B virus effects of traditional Chinese medicine: Learning from clinical trials in the past twenty years 9/25/2025 11:24:00 AM \| Browse: 429 \| Download: 549
24	Chronic hepatitis B: Is it time for expanded antiviral treatment? 9/25/2025 9:22:03 AM \| Browse: 284 \| Download: 434
25	Advancing therapeutic vaccines for chronic hepatitis B: Integrating reverse vaccinology and immunoinformatics 7/25/2025 12:09:41 PM \| Browse: 306 \| Download: 715
26	Chronic hepatitis B with type 2 diabetes mellitus: Association between glycemic control and liver fibrosis 7/15/2025 8:26:32 AM \| Browse: 319 \| Download: 1057
27	Rate of abnormal renal function index and related risk factors in patients with chronic hepatitis B 7/4/2025 9:23:52 AM \| Browse: 224 \| Download: 979
28	Assessing the role of Mac-2 binding protein glycosylation isomer in the management of patients with chronic hepatitis B 5/27/2025 7:04:48 AM \| Browse: 376 \| Download: 1167
29	Microbial characteristics of gut microbiome dysbiosis in patients with chronic liver disease 5/27/2025 7:04:47 AM \| Browse: 334 \| Download: 975
30	Attenuation imaging: Diagnostic differences in hepatic steatosis for chronic hepatitis B vs metabolic dysfunction-associated steatotic liver disease patients 3/13/2025 10:11:05 AM \| Browse: 289 \| Download: 946
31	Tenofovir amibufenamide: A potential alternative for chronic hepatitis B treatment 2/26/2025 4:21:35 AM \| Browse: 285 \| Download: 690
32	CXCR5+CD8+ T cells as immune regulators in HBeAg-positive chronic hepatitis B under interferon-alpha treatment 12/20/2024 3:53:46 AM \| Browse: 115 \| Download: 569
33	Current status of drug therapy for chronic hepatitis B 12/18/2024 7:36:02 AM \| Browse: 342 \| Download: 909
34	Revolutionizing the understanding of liver disease: Metabolism, function and future 11/29/2024 2:50:19 PM \| Browse: 395 \| Download: 1094
35	Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus 11/29/2024 2:50:18 PM \| Browse: 389 \| Download: 1374
36	Recurrence and influencing factors of hepatitis B surface antigen seroclearance induced by peginterferon alpha-based regimens 11/12/2024 6:08:07 AM \| Browse: 191 \| Download: 1230
37	Elimination of hepatitis B as a public health threat: Addressing the challenge and taking action 11/6/2024 9:50:59 AM \| Browse: 320 \| Download: 1061
38	Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway 10/31/2024 10:42:49 AM \| Browse: 364 \| Download: 957
39	Chronic hepatitis B: Prevent, diagnose, and treat before the point of no return 10/21/2024 7:03:25 AM \| Browse: 365 \| Download: 861
40	Liver stiffness in hepatocellular carcinoma and chronic hepatitis patients: Hepatitis B virus infection and transaminases should be considered 7/26/2024 10:33:30 AM \| Browse: 390 \| Download: 1193
41	Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis 7/26/2024 10:33:30 AM \| Browse: 452 \| Download: 1748
42	Effectiveness and safety of tenofovir amibufenamide in chronic hepatitis B patients 7/9/2024 2:00:35 PM \| Browse: 309 \| Download: 826
43	Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase-inhibitors 6/25/2024 10:41:21 AM \| Browse: 422 \| Download: 841
44	Hepatitis B cure: Current situation and prospects 6/20/2024 3:42:22 AM \| Browse: 378 \| Download: 1064
45	Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase 6/20/2024 3:42:22 AM \| Browse: 244 \| Download: 1416
46	Prediction model for hepatitis B e antigen seroconversion in chronic hepatitis B with peginterferon-alfa treated based on a response-guided therapy strategy 3/27/2024 1:28:19 PM \| Browse: 411 \| Download: 1514
47	Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study 3/11/2024 2:44:49 PM \| Browse: 524 \| Download: 1552
48	Risk of hepatitis B virus reactivation in oncological patients treated with tyrosine kinase inhibitors: A case report and literature analysis 3/6/2024 6:10:52 AM \| Browse: 500 \| Download: 1390
49	Effect of viral hepatitis on type 2 diabetes: A Mendelian randomization study 2/4/2024 10:57:42 AM \| Browse: 568 \| Download: 1847
50	Antiviral treatment standards for hepatitis B: An urgent need for expansion 1/26/2024 7:56:29 AM \| Browse: 614 \| Download: 1451

Page 1 of 4 ( 190 items )
<<
1
2
3
4
>>

1	Pegylated interferon α-2b add-on to nucleos(t)ide analogues reduces hepatocellular carcinoma and decompensation in advanced fibrotic chronic hepatitis B 10/15/2026 5:45:55 AM \| Browse: 17 \| Download: 59
2	From virological selection to immune stratification: Hepatitis B virus-specific T cells for precision pegylated interferon therapy in chronic hepatitis B 9/17/2026 5:48:20 AM \| Browse: 33 \| Download: 69
3	Biological interpretation of baseline hepatitis B surface antigen and cirrhosis in determining interferon treatment duration 9/7/2026 2:26:33 AM \| Browse: 45 \| Download: 88
4	Predictive model to identify patients requiring extended interferon therapy in chronic hepatitis B 9/1/2026 6:22:40 AM \| Browse: 32 \| Download: 74
5	Routine laboratory model for identifying significant fibrosis in chronic hepatitis B 6/26/2026 9:50:21 AM \| Browse: 59 \| Download: 262
6	Comparing validated hepatocellular carcinoma risk scores for chronic hepatitis B against current Australian surveillance guidelines 6/26/2026 9:50:19 AM \| Browse: 43 \| Download: 218
7	Letter to the Editor: Physical functioning as a neglected determinant of antiviral adherence in chronic hepatitis B 6/18/2026 7:52:55 AM \| Browse: 59 \| Download: 250
8	Bone and renal safety of initial antiviral therapy using tenofovir alafenamide fumarate or entecavir for chronic hepatitis B 5/29/2026 7:26:46 AM \| Browse: 57 \| Download: 347
9	Beyond fibrosis: The imperative for dual steatosis and fibrosis assessment in chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease co-pathology 5/26/2026 3:52:09 AM \| Browse: 44 \| Download: 206
10	Diagnostic efficacy and influencing factors of non-invasive liver fibrosis scores in chronic hepatitis B fibrosis: Cross-sectional study 5/26/2026 3:52:08 AM \| Browse: 68 \| Download: 294
11	Why does hepatitis B remain underprioritized? A view through lived experience 4/23/2026 11:05:50 AM \| Browse: 101 \| Download: 335
12	Baseline hepatitis B surface antigen and cirrhosis predict extended interferon therapy in chronic hepatitis B: A retrospective study 3/19/2026 7:07:29 AM \| Browse: 101 \| Download: 411
13	Predictive tool for evident histological liver injury in chronic hepatitis B patients: Development and validation 2/12/2026 11:20:21 AM \| Browse: 141 \| Download: 584
14	Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B 2/12/2026 11:20:19 AM \| Browse: 142 \| Download: 586
15	Adherence to antiviral treatment among people living with chronic hepatitis B: A global survey 12/25/2025 9:13:55 AM \| Browse: 117 \| Download: 518
16	Retreatment hepatitis B surface antigen clearance prediction model identifies pegylated interferon alpha candidates in chronic hepatitis B 11/28/2025 3:10:38 AM \| Browse: 304 \| Download: 634
17	Meta-analysis of factors associated with the incidence of comorbid depression and anxiety in patients with chronic hepatitis B 11/4/2025 2:41:47 AM \| Browse: 317 \| Download: 770
18	Gray zone and the need for expansion in chronic hepatitis B: From theory to clinical practice 10/27/2025 10:57:50 AM \| Browse: 438 \| Download: 614
19	Association of serum hepatitis B surface antigen with hepatitis B virus DNA and hepatic function in patients with chronic hepatitis B 10/24/2025 7:36:34 AM \| Browse: 362 \| Download: 555
20	Association between hepatitis B virus markers and liver fibrosis staging in patients with chronic hepatitis B 10/24/2025 7:36:26 AM \| Browse: 219 \| Download: 467
21	Psychological distress and treatment adherence-challenges of patients with chronic hepatitis B: Risk factors and integrated nursing strategies 9/26/2025 8:18:47 AM \| Browse: 569 \| Download: 579
22	Functional cure in an occult hepatitis B virus infection patient on sequential therapy: A case report 9/25/2025 11:24:05 AM \| Browse: 189 \| Download: 589
23	Anti-hepatitis B virus effects of traditional Chinese medicine: Learning from clinical trials in the past twenty years 9/25/2025 11:24:00 AM \| Browse: 429 \| Download: 549
24	Chronic hepatitis B: Is it time for expanded antiviral treatment? 9/25/2025 9:22:03 AM \| Browse: 284 \| Download: 434
25	Advancing therapeutic vaccines for chronic hepatitis B: Integrating reverse vaccinology and immunoinformatics 7/25/2025 12:09:41 PM \| Browse: 306 \| Download: 715
26	Chronic hepatitis B with type 2 diabetes mellitus: Association between glycemic control and liver fibrosis 7/15/2025 8:26:32 AM \| Browse: 319 \| Download: 1057
27	Rate of abnormal renal function index and related risk factors in patients with chronic hepatitis B 7/4/2025 9:23:52 AM \| Browse: 224 \| Download: 979
28	Assessing the role of Mac-2 binding protein glycosylation isomer in the management of patients with chronic hepatitis B 5/27/2025 7:04:48 AM \| Browse: 376 \| Download: 1167
29	Microbial characteristics of gut microbiome dysbiosis in patients with chronic liver disease 5/27/2025 7:04:47 AM \| Browse: 334 \| Download: 975
30	Attenuation imaging: Diagnostic differences in hepatic steatosis for chronic hepatitis B vs metabolic dysfunction-associated steatotic liver disease patients 3/13/2025 10:11:05 AM \| Browse: 289 \| Download: 946
31	Tenofovir amibufenamide: A potential alternative for chronic hepatitis B treatment 2/26/2025 4:21:35 AM \| Browse: 285 \| Download: 690
32	CXCR5+CD8+ T cells as immune regulators in HBeAg-positive chronic hepatitis B under interferon-alpha treatment 12/20/2024 3:53:46 AM \| Browse: 115 \| Download: 569
33	Current status of drug therapy for chronic hepatitis B 12/18/2024 7:36:02 AM \| Browse: 342 \| Download: 909
34	Revolutionizing the understanding of liver disease: Metabolism, function and future 11/29/2024 2:50:19 PM \| Browse: 395 \| Download: 1094
35	Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus 11/29/2024 2:50:18 PM \| Browse: 389 \| Download: 1374
36	Recurrence and influencing factors of hepatitis B surface antigen seroclearance induced by peginterferon alpha-based regimens 11/12/2024 6:08:07 AM \| Browse: 191 \| Download: 1230
37	Elimination of hepatitis B as a public health threat: Addressing the challenge and taking action 11/6/2024 9:50:59 AM \| Browse: 320 \| Download: 1061
38	Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway 10/31/2024 10:42:49 AM \| Browse: 364 \| Download: 957
39	Chronic hepatitis B: Prevent, diagnose, and treat before the point of no return 10/21/2024 7:03:25 AM \| Browse: 365 \| Download: 861
40	Liver stiffness in hepatocellular carcinoma and chronic hepatitis patients: Hepatitis B virus infection and transaminases should be considered 7/26/2024 10:33:30 AM \| Browse: 390 \| Download: 1193
41	Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis 7/26/2024 10:33:30 AM \| Browse: 452 \| Download: 1748
42	Effectiveness and safety of tenofovir amibufenamide in chronic hepatitis B patients 7/9/2024 2:00:35 PM \| Browse: 309 \| Download: 826
43	Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase-inhibitors 6/25/2024 10:41:21 AM \| Browse: 422 \| Download: 841
44	Hepatitis B cure: Current situation and prospects 6/20/2024 3:42:22 AM \| Browse: 378 \| Download: 1064
45	Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase 6/20/2024 3:42:22 AM \| Browse: 244 \| Download: 1416
46	Prediction model for hepatitis B e antigen seroconversion in chronic hepatitis B with peginterferon-alfa treated based on a response-guided therapy strategy 3/27/2024 1:28:19 PM \| Browse: 411 \| Download: 1514
47	Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study 3/11/2024 2:44:49 PM \| Browse: 524 \| Download: 1552
48	Risk of hepatitis B virus reactivation in oncological patients treated with tyrosine kinase inhibitors: A case report and literature analysis 3/6/2024 6:10:52 AM \| Browse: 500 \| Download: 1390
49	Effect of viral hepatitis on type 2 diabetes: A Mendelian randomization study 2/4/2024 10:57:42 AM \| Browse: 568 \| Download: 1847
50	Antiviral treatment standards for hepatitis B: An urgent need for expansion 1/26/2024 7:56:29 AM \| Browse: 614 \| Download: 1451